Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat
- PMID: 1317040
- DOI: 10.1007/BF02244975
Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat
Abstract
The cataleptogenic effect of delta 9-THC was compared to its discriminative stimulus effects in rats. The ED50s for the discriminative stimulus and catalepsy were 0.8 and 4.0 mg/kg, respectively, while their time courses were very similar. The ED50 of delta 9-THC for catalepsy in experimentally naive rats was not different from that in rats trained with the drug discrimination procedure, indicating that the cataleptogenic effect was not appreciably attenuated by long-term exposure to low doses of delta 9-THC. Pharmacologically, the catalepsy produced by delta 9-THC more closely resembled that of haloperidol than of morphine, since anticholinergic pretreatment eliminated the delta 9-THC-induced catalepsy while pre-treatment with naloxone had no effect. Although the cataleptogenic effect of delta 9-THC could be pharmacologically manipulated by anticholinergic pre-treatment, its discriminative stimulus effects were not changed in the same animals. These results demonstrate that distinctive mechanisms of action exist for these cannabinoid-induced behaviors.
Similar articles
-
Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.Psychopharmacology (Berl). 2005 Jun;179(4):804-12. doi: 10.1007/s00213-004-2118-x. Epub 2004 Dec 24. Psychopharmacology (Berl). 2005. PMID: 15619107
-
Noradrenergic involvement in catalepsy induced by delta 9-tetrahydrocannabinol.Neuropharmacology. 1987 Jan;26(1):55-60. doi: 10.1016/0028-3908(87)90044-x. Neuropharmacology. 1987. PMID: 3031535
-
Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.Eur J Pharmacol. 1983 Oct 28;94(3-4):349-51. doi: 10.1016/0014-2999(83)90427-2. Eur J Pharmacol. 1983. PMID: 6317407
-
Discriminative stimulus effects of phencyclidine: pharmacologically specific interactions with delta 9- and delta 8-tetrahydrocannabinol.Drug Alcohol Depend. 1994 Apr;35(2):151-8. doi: 10.1016/0376-8716(94)90122-8. Drug Alcohol Depend. 1994. PMID: 8055736
-
Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication.Neurosci Biobehav Rev. 1992 Spring;16(1):55-62. doi: 10.1016/s0149-7634(05)80051-x. Neurosci Biobehav Rev. 1992. PMID: 1313164 Review.
Cited by
-
Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Parkinsons Dis. 2016;2016:1279042. doi: 10.1155/2016/1279042. Epub 2016 Dec 5. Parkinsons Dis. 2016. PMID: 28050308 Free PMC article. Review.
-
Assessing Allosteric Modulation of CB1 at the Receptor and Cellular Levels.Methods Enzymol. 2017;593:317-342. doi: 10.1016/bs.mie.2017.05.002. Epub 2017 Jul 5. Methods Enzymol. 2017. PMID: 28750809 Free PMC article.
-
Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride.Neuropharmacology. 2012 Feb;62(2):1019-27. doi: 10.1016/j.neuropharm.2011.10.011. Epub 2011 Oct 31. Neuropharmacology. 2012. PMID: 22051632 Free PMC article.
-
Endocannabinoid modulation of dopaminergic motor circuits.Front Pharmacol. 2012 Jun 12;3:110. doi: 10.3389/fphar.2012.00110. eCollection 2012. Front Pharmacol. 2012. PMID: 22701427 Free PMC article.
-
Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.Psychopharmacology (Berl). 2005 Jun;179(4):804-12. doi: 10.1007/s00213-004-2118-x. Epub 2004 Dec 24. Psychopharmacology (Berl). 2005. PMID: 15619107
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources